TRANSLATIONAL SCIENCES, INC.

Basic Information

1840 Overton Park Avenue
Memphis, TN, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 803592364
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Reducing Stroke by a Novel, Clot-dissolving Antibody

    Amount: $2,999,979.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. Novel Methods for Dissolving Blood Clots

    Amount: $1,519,440.00

    DESCRIPTION (provided by applicant): Each year, as many as 2 million Americans develop venous thromboembolism (VTE). VTEs are blood clots in the legs (venous thrombosis) that may travel to the lungs ( ...

    STTR Phase II 2012 Department of Health and Human Services
  3. Reducing Stroke by a Novel, Clot-dissolving Antibody

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to ...

    SBIR Phase I 2011 Department of Health and Human Services
  4. Novel Methods for Dissolving Blood Clots

    Amount: $167,685.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death worldwide. Current therapies for cardiovascular disease are associated with partial success, restricted access ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government